Manchester Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.5K | Buy |
2,427
+189
| +8% | +$2.92K | ﹤0.01% | 619 |
|
|
2025
Q1 | $33.3K | Buy |
2,238
+46
| +2% | +$684 | ﹤0.01% | 624 |
|
|
2024
Q4 | $29K | Buy |
2,192
+161
| +8% | +$2.13K | ﹤0.01% | 652 |
|
|
2024
Q3 | $28.9K | Buy |
2,031
+215
| +12% | +$3.06K | ﹤0.01% | 642 |
|
|
2024
Q2 | $23.5K | Buy |
1,816
+1,334
| +277% | +$17.3K | ﹤0.01% | 635 |
|
|
2024
Q1 | $6.7K | Hold |
482
| – | – | ﹤0.01% | 688 |
|
|
2023
Q4 | $6.88K | Sell |
482
-183
| -28% | -$2.61K | ﹤0.01% | 655 |
|
|
2023
Q3 | $10.3K | Sell |
665
-53
| -7% | -$820 | ﹤0.01% | 579 |
|
|
2023
Q2 | $11.3K | Buy |
718
+153
| +27% | +$2.4K | ﹤0.01% | 536 |
|
|
2023
Q1 | $9.31K | Hold |
565
| – | – | ﹤0.01% | 555 |
|
|
2022
Q4 | $8.81K | Buy |
565
+62
| +12% | +$967 | ﹤0.01% | 475 |
|
|
2022
Q3 | $7K | Sell |
503
-325
| -39% | -$4.52K | ﹤0.01% | 481 |
|
|
2022
Q2 | $12K | Sell |
828
-4
| -0.5% | -$58 | ﹤0.01% | 462 |
|
|
2022
Q1 | $12K | Buy |
832
+190
| +30% | +$2.74K | ﹤0.01% | 524 |
|
|
2021
Q4 | $9K | Sell |
642
-15
| -2% | -$210 | ﹤0.01% | 580 |
|
|
2021
Q3 | $11K | Buy |
657
+159
| +32% | +$2.66K | ﹤0.01% | 582 |
|
|
2021
Q2 | $8K | Sell |
498
-170
| -25% | -$2.73K | ﹤0.01% | 520 |
|
|
2021
Q1 | $12K | Hold |
668
| – | – | ﹤0.01% | 470 |
|
|
2020
Q4 | $12K | Hold |
668
| – | – | ﹤0.01% | 468 |
|
|
2020
Q3 | $12K | Hold |
668
| – | – | ﹤0.01% | 415 |
|
|
2020
Q2 | $12K | Hold |
668
| – | – | ﹤0.01% | 459 |
|
|
2020
Q1 | $10K | Hold |
668
| – | – | ﹤0.01% | 463 |
|
|
2019
Q4 | $13K | Buy |
+668
| New | +$13K | ﹤0.01% | 455 |
|